The U.S. Food and Drug Administration on Tuesday approved GSK's drug for a common type of urinary tract infection (UTI) in ...

GSK said on Tuesday that it is studying a group of more than a million older adults in the UK to examine whether its ...

The U.S. Food and Drug Administration on Tuesday approved GSK's drug for a common type of urinary tract infection (UTI) in ...

For GSK’s Ramakrishnan, who has served as CDTO since 2021, the biggest challenge was helping her company get a head start in ...

GSK PLC closed 18.56% short of its 52-week high of £18.24, which the company achieved on May 16th.

Shares of GSK PLC GSK slipped 1.73% to £15.05 Wednesday, on what proved to be an all-around positive trading session for the ...

NEW YORK, NY / ACCESS Newswire / March 19, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers ...

The study will analyse electronic health records of 65- and 66-year olds from the UK’s National Health Service (NHS).

GSK is opening the door to a new era in urinary tract infection (UTI) treatment with its Blujepa, the first in a new class of ...

The British pharmaceutical giant is working with the U.K. Dementia Research Institute to exploit a “natural randomization” ...

GSK, led by boss Emma Walmsley (pictured), is using the data of 1.4m adults aged 65 and 66 to examine the impact of its ...

The approval was based on data from two late-stage trials showing the drug was superior to nitrofurantoin, the ...